SPONSORED: Growing revenues put Creso Pharma in box seat to capitalise on positive cannabis momentum. Listed cannabis company Creso Pharma looks to have started 2021 as it finished 2020
FNArena will resume operations from Monday, 11th January, gradually
Peter Switzer of the Switzer Report highlights ten stocks under recent pressure he’s prepared to buy for a comeback.
SPONSORED: ASX cannabis stocks are gaining momentum, stimulated by significant developments in the global regulatory environments in recent months
Peter Switzer of the Switzer Report debates the merits of buying stocks impacted by the Chinese trade war while prices are down.
SPONSORED: The prices of precious metals (gold and silver) have experienced a slight pullback in recent months. For many, particularly leveraged early stage stocks, this suggests a likely return to form in the early months of 2021
SPONSORED: Minbos Resources last week announced a Memorandum of Understanding (MOU) with the International Fertilizer Development Centre (IDFC), which will work to develop and grow the Small Holder Farmer market in Angola
Peter Switzer of the Switzer Report highlights yield-seeking ETFs for the longer term investor
SPONSORED: 88 Energy Ltd this week executed its drilling contract to drill the Merlin-1 and Harrier-1 wells for Project Peregrine on the North Slope of Alaska
SPONSORED: Investors and cannabis stocks the world over have been buoyed by positive regulatory news from the United States, with the House of Representatives passing the Marijuana Opportunity Reinvestment and Expungement (MORE) Act to remove cannabis for the US Controlled Substances Act